October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
|Articles|April 11, 2022
Daily OTC Pearl: Move Free
Author(s)Saro Arakelians, PharmD
Move Free is intended to support joint health and help with osteoarthritis pain.
Advertisement
OTC/Lifestyle Pearl of the Day: Move Free
Indication: Move Free is intended to support joint health and help with osteoarthritis pain.
Insight:
- Chondroitin is a naturally occurring substance formed of sugar chains. It is believed to help the body maintain fluid and flexibility in the joints.
- Glucosamine is sugar protein that helps the body build cartilage. Glucosamine is a naturally occurring substance found in bones, bone marrow, shellfish, and fungus.
- Schiff Move Free is a combination product that has been used in alternative medicine in treating
osteoarthritis pain. - Other uses not proven with research have included treating
rheumatoid arthritis ,osteoporosis , cataracts,glaucoma , bladder problems, heart disease,high cholesterol , or temporomandibular joint disease. - Directions: Take as directed per the instructions on the bottle.
Source:
Advertisement
Related to this article
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
Expert Q&A: Geisinger Investigator Discusses Low Flu Vaccination Rates, ICU Findings in Older Adults
A study author explains how pharmacists can help close vaccination gaps in rural communities and what lower ICU admission rates among vaccinated older adults may mean.
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Kidney Week 2026 posters show low-density lipoprotein cholesterol (LDL-C) fell by half in patients receiving dialysis, and oral enlicitide needed no dose adjustment for renal impairment.
Walgreens adds virtual coverage navigation, Medicare GLP-1 Bridge support, and pharmacist follow-up calls as GLP-1 discontinuation remains high.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Happens Before the First Dose? 5 Steps That Shape Lung Cancer Treatment
2
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
Nicotine Vaping Linked to Lower Vascular Function in Young Adults
4
Full IDWeek Data Highlights 31-Valent Pneumococcal Conjugate Vaccine Candidate in Adults
5